| Revenues | 12.6M |
| Cost of sales | 7.28M |
| Selling, general and administrative | 5.79M |
| Gain on revaluation of ACT liability | |
| Research and development | 1.3M |
| [OperatingExpenses] | |
| Operating income (loss) | -2.88M |
| Interest expense | 0 |
| Interest income | 5K |
| Other expense | -254K |
| Income before income taxes | -3.13M |
| Income tax (expense) benefit | 114K |
| Net income (loss) | -3.02M |
| Basic (in Dollars per share) | -0.13 |
| Diluted (in Dollars per share) | -0.13 |
| Basic (in Shares) | 23.45M |
| Diluted (in Shares) | 23.45M |